Cargando…
Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice
BACKGROUND: T2DM is a high-risk pregnancy with adverse fetal and maternal outcomes including repeated miscarriages and fetal malformations. Despite the established association between placental insufficiency and poor maternal Th1-adaptability to the development of pregnancy complications in T2DM, th...
Autores principales: | Albaghdadi, Ahmad J. H., Hewitt, Melanie A., Putos, Samantha M., Wells, Michael, Ozolinš, Terence R. S., Kan, Frederick W. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307666/ https://www.ncbi.nlm.nih.gov/pubmed/28193233 http://dx.doi.org/10.1186/s12967-017-1137-4 |
Ejemplares similares
-
The status of diabetic embryopathy
por: Eriksson, Ulf J., et al.
Publicado: (2016) -
Challenges in Understanding Diabetic Embryopathy
por: Loeken, Mary R.
Publicado: (2008) -
Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2019) -
Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2021) -
Retinoic Acid Embryopathy
por: Mondal, Dipankar, et al.
Publicado: (2017)